Medicare receives the lion's share of attention where coverage and reimbursement are concerned, but at least one venture capitalist deeply involved in med-tech says private payers have historically been more stringent, and are becoming more so. Jack Lasersohn of the Vertical Group (Summit, New Jersey) told Medical Device Daily, "I think it is more coverage" than reimbursement that is the issue with regard to private payers. He also said this is no reflexive approach to a slippery coverage slope, stating, "I think this is a very conscious raising of the bar" on the part of private payers. Read More
